Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
Clinical trial NCT06190509 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06190509
- Sponsor
- LimmaTech Biologics AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2027-04-30
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.